1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Healthcare Plans
Centene Corp.

Centene Corp.

CNC
Centene Corp.US flagNew York Stock Exchange
61.91
USD
-0.17
- -
30.58BMarket Cap
Centene Corp.
CNC
(New York Stock Exchange)

Recent

price

61.91

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
22.81
25.95
39.36
50.17
71.17
95.55
127.24
140.24
154.05
180.51
194.69
216.15
251.3
283.44
312.52
394.99
412.36
Revenue per Share
0.49
0.55
0.01
0.76
1.16
1.49
1.76
2.4
2.31
3.19
3.17
2.31
2.09
4.97
6.33
-13.53
-10.36
Basic EPS, GAAP
0.87
1.3
1.35
1.76
5.26
2.76
5.8
4.32
3.16
3.59
9.64
7.21
10.89
14.82
0.3
10.32
19.81
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
4
4.6
4.55
5.58
7.36
8.96
17.14
19.75
26.47
30.24
44.32
46
43.68
48.35
53.26
40.57
45.67
Book Value per Share
2.45
3.08
3.23
3.78
3.67
4.82
-1.05
2.03
4.03
8.73
-2.18
-1.37
-3.02
4.08
6.94
9.33
15.23
Tangible Book Value per Share
195
201
206
217
233
238
319
345
390
413
571
583
575
543
522
493
492
Basic Weighted Avg Shares
4,448
5,211
8,110
10,863
16,560
22,760
40,607
48,382
60,116
74,639
111,115
125,982
144,547
153,999
163,071
194,777
202,938
Sales/Revenue/Turnover
3.53
3.91
1.68
2.55
2.8
3.1
3.11
2.48
2.43
2.75
2.84
2.59
2.52
2.25
1.95
-0.16
0.8
Operating Margin (%)
52
58
66
67
89
111
278
361
495
643
1,259
1,335
1,430
1,293
1,241
1,275
1,246
Depreciation Expense
95
111
2
165
271
355
562
828
900
1,321
1,808
1,347
1,202
2,702
3,305
-6,674
-5,100
Net Income, GAAP
38.83
37.53
38.21
39.78
42.89
48.64
51.64
28.75
34.65
26.54
35.3
26.31
38.74
24.99
22.62
- -
53.53
Effective Tax Rate (%)
2.13
2.13
0.02
1.52
1.64
1.56
1.38
1.71
1.5
1.77
1.63
1.07
0.83
1.75
2.03
-3.43
-2.51
Profit Margin (%)
-108
102
177
241
51
-24
-258
-629
27
7,391
1,808
2,732
1,664
4,040
3,738
3,674
5,926
Working Capital
328
348
535
666
874
1,216
4,651
4,695
6,648
14,260
16,682
22,190
21,071
18,590
19,161
17,966
16,030
LT Debt
797
936
954
1,243
1,891
2,324
6,054
6,876
11,023
12,692
25,962
27,022
24,237
25,956
26,510
20,056
22,657
Total Equity
9.36
10.54
6.05
9.8
11.32
11.47
8.57
7.67
6.51
6.74
5.87
5.22
4.69
5.76
5.45
- -
- -
Return on Invested Capital (%)
9.97
10.5
1.97
10.59
12.73
11.88
9.37
9.24
7.72
7.28
6.56
4
3.38
7.19
8.5
- -
-21.27
Return on Capital (%)
13.6
12.86
0.21
15.09
18.2
18.2
13.96
12.99
10.13
11.26
9.44
5.12
4.73
10.83
12.65
-28.79
-20.41
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
196
63
75
LT Borrowings
17,351
16,308
16,030
LT Finance Leases
615
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
492
494
494
Market Capitalization
20,236
16,166
31,709

Working Capital

FRC

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
40,370
44,989
46,685
Cash, Cash Equivalents & STI
20,320
23,741
27,057
Accounts Receivable, Net
18,105
19,426
18,076
Inventories
- -
- -
- -
Total Current Liabilities
36,696
40,045
40,759
Payables & Accruals
15,220
18,402
19,716
ST Debt
196
63
75
Deferred Revenue
736
953
706

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
33.27%
-4.27%
-24.35%
Free Cash Flow
359.56%
631.95%
3,203.9%
Net Income, GAAP
0.69%
-38.22%
-301.94%
Sales/Revenue/Turnover
25.48%
12%
19.44%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
40,407
39,836
42,023
40,805
163,071
2025
46,620
48,742
49,690
49,725
194,777
2026
49,944
53,579
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2.17
2.16
1.37
0.57
6.33
2025
2.64
-0.51
-13.5
-2.24
-13.53
2026
3.13
2.21
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Hapvida Participações e Investimentos S.A. (HAPV3.SA)
CVS Health Corporation (0HRS.L)
Aetna Inc. (AET)
Universal American Corporation (UAM)
Middlefield Healthcare Dividend ETF (LS.TO)
Elevance Health, Inc. (0HG8.L)
Business
Centene Corporation Centene Corporation manages a leading portfolio of government-sponsored healthcare programs, including Medicaid, Medicare Advantage, Medicare Prescription Drug Plans, Health Insurance Marketplace plans under the Ambetter brand, and TRICARE; it offers services through subsidiaries such as Wellcare for Medicare products and Envolve for pharmacy benefits management, alongside correctional healthcare via Centurion. Headquartered in St. Louis, Missouri, the company operates across all 50 states, serving more than 27 million members, primarily low-income, under-insured, and uninsured individuals, with a local approach featuring community-based health plans and innovative programs focused on physical health, emotional wellness, and social determinants of health. Founded in 1984 as a nonprofit Medicaid plan, Centene Corporation went public in 2001 and has expanded through strategic acquisitions like Wellcare in recent years; in 2024, it sold Collaborative Health Systems to Astrana Health and announced the divestiture of Magellan Specialty Health to Evolent Health, while entering a new credit agreement in March 2025 to support ongoing operations amid robust revenue growth to $44.9 billion in premium and service revenues for Q3 2025.

Company News

Company News APIChatGPT

  • zacks.com

    Best Growth Stocks to Buy for September 24th

  • prnewswire.com

    Health Net Providing Special Assistance to Members and Providers Affected by Weather Events Statewide and Robin Lane Sewage Spill in Lake County

  • prnewswire.com

    Stockton Seniors Gain Access to 76 Affordable Homes with Health Net's $3 Million Investment

  • zacks.com

    Is Centene (CNC) Stock Outpacing Its Medical Peers This Year?

  • zacks.com

    3 Momentum Anomaly Stocks to Buy as Markets Surge on AI Rally

  • zacks.com

    How Centene's Strong Cash Flow Is Reshaping Its Balance Sheet

  • zacks.com

    Best Growth Stocks to Buy for September 22nd

  • zacks.com

    Centene (CNC) is a Top-Ranked Momentum Stock: Should You Buy?

  • marketbeat.com

    Centene Reaffirms 2026 EPS Outlook as Medicaid Membership Decline Deepens

  • zacks.com

    Employer Health Costs Surge: What it Means for EHTH, CNC & UNH

  • zacks.com

    Is Centene (CNC) Stock Undervalued Right Now?

  • zacks.com

    Best Growth Stocks to Buy for September 18th

  • zacks.com

    Can Centene Sustain Its Turnaround Amid Membership Pressure?

  • zacks.com

    4 Value Stocks to Buy as Fed Rate Hikes Test Wall Street

  • seekingalpha.com

    Centene Corporation (CNC) Presents at Deutsche Bank 2026 Healthcare Summit Transcript

  • zacks.com

    Oscar Health vs. Centene: Which ACA Insurer Is the Better Buy?

  • zacks.com

    Best Growth Stocks to Buy for September 16th

  • zacks.com

    4 Stocks Trading Near 52-Week High With More Upside Potential

  • zacks.com

    5 Low P/B Stocks That Offer Attractive Value and Growth

  • zacks.com

    Centene Corporation (CNC) Hit a 52 Week High, Can the Run Continue?